More on LFCR
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $6.33 |
|
|||
| Open | $6.33 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $6.33 | ||||
| Day Low | $6.33 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 134 | ||||
- Form 8-K LIFECORE BIOMEDICAL, For: Apr 15
- Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
- Form NT 10-Q LIFECORE BIOMEDICAL, For: Feb 25
- Lifecore Biomedical (LFCR) PT Lowered to $6 at Stephens
- Form 8-K LIFECORE BIOMEDICAL, For: Apr 01
- Lifecore Biomedical Provides Business Update Outlining Fiscal 2024 Outlook and Year-to-date Progress
- Form 8-K LIFECORE BIOMEDICAL, For: Mar 20
- Lifecore Biomedical (LFCR) Announces Pending Change of Auditor and Provides Expectation for Business Update
- Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update
- LIFECORE ALERT: Bragar Eagel & Squire, P.C. is Investigating Lifecore Biomedical, Inc. on Behalf of Lifecore Stockholders and Encourages Investors to Contact the Firm
Entities mentioned with LFCR
- Earnings | View Related Stories »
- Legion Partners | View Related Stories »
- Wynnefield Capital | View Related Stories »
- Dividend | View Related Stories »
- IPO | View Related Stories »
- Shamrock Activist Value Fund | View Related Stories »
- Citi | View Related Stories »
- Definitive Agreement | View Related Stories »
- Show More...
